Clinical Trials Browser

Phase 1 × INDUSTRY × inebilizumab × Clear all

NCT01957579 2017-06-12

A Phase 1, Dose-escalation Study of MEDI-551 in Japanese Adult Patients With Relapsed or Refractory Advanced B-cell Malignancies

Phase 1 Completed

32 enrolled 23 charts

Other hematologic neoplasm

Hematologic Neoplasms